Top

Published in:

01-02-2017 | Surgery and Surgical Innovations in Colorectal Cancer (S Huerta, Section Editor)

Lymphadenectomy in Colorectal Cancer: Therapeutic Role and How Many Nodes Are Needed for Appropriate Staging?

Authors: Jeonghee Han, Kyung Tae Noh, Byung Soh Min

Published in: Current Colorectal Cancer Reports | Issue 1/2017

Abstract

Surgical resection with adequate lymphadenectomy is the treatment of choice for accurate diagnosis and proper treatment in colorectal cancer. Lymph node (LN) staging is an important prognostic factor in colorectal cancer and remains to be the most main criteria to select patients for adjuvant treatment. In colorectal cancer, a focus of treatment has been to collect as many LNs as possible to improve staging and increase survival. However, the scientific evidence for a minimum LN harvest remains controversial and the use of international cut-off values should be considered again. In practice, a thorough pursuit of a set high number of LNs may not be appropriate, but the best practice should be to collect as many LNs as possible.

Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.21332.PubMedCrossRef

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4. doi:10.1245/s10434-010-0985-4.PubMedCrossRef

Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes’ C class of colorectal cancer. An analysis of the NSABP clinical trials. Ann Surg. 1986;203(2):115–22.PubMedPubMedCentralCrossRef

Leen E, Goldberg JA, Robertson J, Angerson WJ, Sutherland GR, Cooke TG, et al. Early detection of occult colorectal hepatic metastases using duplex colour Doppler sonography. Br J Surg. 1993;80(10):1249–51.PubMedCrossRef

Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer. 1984;53(6):1354–62.PubMedCrossRef

Cawthorn SJ, Parums DV, Gibbs NM, A’Hern RP, Caffarey SM, Broughton CI, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet (Lond, Engl). 1990;335(8697):1055–9.CrossRef

Enker WE, Laffer UT, Block GE. Enhanced survival of patients with colon and rectal cancer is based upon wide anatomic resection. Ann Surg. 1979;190(3):350–60.PubMedPubMedCentralCrossRef

Harnsberger JR, Vernava 3rd VM, Longo WE. Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer. Dis Colon Rectum. 1994;37(1):73–87.PubMedCrossRef

Goldberg PA, Nicholls RJ. Prediction of local recurrence and survival of carcinoma of the rectum by surgical and histopathological assessment of local clearance. Br J Surg. 1995;82(8):1054–6.PubMedCrossRef

10.

Rosemurgy AS, Block GE, Shihab F. Surgical treatment of carcinoma of the abdominal colon. Surg Gynecol Obstet. 1988;167(5):399–406.PubMed

11.

• Swartling T, Kalebo P, Derwinger K, Gustavsson B, Kurlberg G. Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer. World J Gastroenterol. 2013;19(21):3263–71. doi:10.3748/wjg.v19.i21.3263. This study gives an update on the evidence supporting lymph node counts in the pCRT setting.PubMedPubMedCentralCrossRef

12.

Deodhar KK, Budukh A, Ramadwar M, Bal MM, Shrikhande SV. Are we achieving the benchmark of retrieving 12 lymph nodes in colorectal carcinoma specimens? Experience from a tertiary referral center in India and review of literature. Indian J Pathol Microbiol. 2012;55(1):38–42. doi:10.4103/0377-4929.94853.PubMedCrossRef

13.

Fingerhut A. What counts most in the lymph node count for colorectal cancer? Surg Innov. 2012;19(3):213–5. doi:10.1177/1553350612458547.PubMedCrossRef

14.

Kuo YH, Lee KF, Chin CC, Huang WS, Yeh CH, Wang JY. Does body mass index impact the number of LNs harvested and influence long-term survival rate in patients with stage III colon cancer? Int J Colorectal Dis. 2012;27(12):1625–35. doi:10.1007/s00384-012-1496-5.PubMedCrossRef

15.

McDonald JR, Renehan AG, O’Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg. 2012;4(1):9–19. doi:10.4240/wjgs.v4.i1.9.PubMedPubMedCentralCrossRef

16.

Saklani AP, Udy T, Chandrasekaran TV, Davies M, Beynon J. Lymph node harvest in Dukes’ a cancer pathologist may need to consider fat dissolving technique: an observational study. Scientific World Journal. 2012;2012:919464. doi:10.1100/2012/919464.PubMedPubMedCentralCrossRef

17.

Bamboat ZM, Deperalta D, Dursun A, Berger DL, Bordeianou L. Factors affecting lymph node yield from patients undergoing colectomy for cancer. Int J Colorectal Dis. 2011;26(9):1163–8. doi:10.1007/s00384-011-1240-6.PubMedCrossRef

18.

Barbas A, Turley R, Mantyh C, Migaly J. Advanced fellowship training is associated with improved lymph node retrieval in colon cancer resections. J Surg Res. 2011;170(1):e41–6. doi:10.1016/j.jss.2011.03.055.PubMedCrossRef

19.

Lagoudianakis E, Pappas A, Koronakis N, Tsekouras D, Dallianoudis J, Kontogianni P, et al. Lymph node harvesting in colorectal carcinoma specimens. Tumori. 2011;97(1):74–8.PubMed

20.

Leung AM, Scharf AW, Vu HN. Factors affecting number of lymph nodes harvested in colorectal cancer. J Surg Res. 2011;168(2):224–30. doi:10.1016/j.jss.2009.09.001.PubMedCrossRef

21.

Qiu HB, Zhang LY, Li YF, Zhou ZW, Keshari RP, Xu RH. Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer. Ann Surg Oncol. 2011;18(6):1568–74. doi:10.1245/s10434-010-1528-8.PubMedCrossRef

22.

Song YX, Gao P, Wang ZN, Tong LL, Xu YY, Sun Z, et al. Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes? PLoS One. 2011;6(12):e28937. doi:10.1371/journal.pone.0028937.PubMedPubMedCentralCrossRef

23.

Dekker JW, Peeters KC, Putter H, Vahrmeijer AL, van de Velde CJ. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol: J Eur Soc Surg Oncolo Br Assoc Surg Oncol. 2010;36(12):1180–6. doi:10.1016/j.ejso.2010.09.007.CrossRef

24.

Hernanz F, Garcia-Somacarrera E, Fernandez F. The assessment of lymph nodes missed in mesenteric tissue after standard dissection of colorectal cancer specimens. Color Dis: Off J Assoc Coloproctology Great Brit Irel. 2010;12(7 Online):e57–60. doi:10.1111/j.1463-1318.2009.01987.x.

25.

Huh JW, Kim YJ, Kim HR. Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol. 2010;17(10):2640–6. doi:10.1245/s10434-010-1015-2.PubMedCrossRef

26.

Marks JH, Valsdottir EB, Rather AA, Nweze IC, Newman DA, Chernick MR. Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum. 2010;53(7):1023–9. doi:10.1007/DCR.0b013e3181dadeb4.PubMedCrossRef

27.

Nir S, Greenberg R, Shacham-Shmueli E, White I, Schneebaum S, Avital S. Number of retrieved lymph nodes and survival in node-negative patients undergoing laparoscopic colorectal surgery for cancer. Tech Coloproctol. 2010;14(2):147–52. doi:10.1007/s10151-010-0578-z.PubMedCrossRef

28.

Norwood MG, Sutton AJ, West K, Sharpe DP, Hemingway D, Kelly MJ. Lymph node retrieval in colorectal cancer resection specimens: national standards are achievable, and low numbers are associated with reduced survival. Color Dis: Off J Assoc Coloproctology Great Brit Irel. 2010;12(4):304–9. doi:10.1111/j.1463-1318.2009.01788.x.CrossRef

29.

Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW, et al. The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg. 2010;251(6):1070–8. doi:10.1097/SLA.0b013e3181d7789d.PubMedCrossRef

30.

Valsecchi ME, Leighton Jr J, Tester W. Modifiable factors that influence colon cancer lymph node sampling and examination. Clin Colorectal Cancer. 2010;9(3):162–7. doi:10.3816/CCC.2010.n.022.PubMedCrossRef

31.

Hsu CW, Lin CH, Wang JH, Wang HT, Ou WC, King TM. Factors that influence 12 or more harvested lymph nodes in early-stage colorectal cancer. World J Surg. 2009;33(2):333–9. doi:10.1007/s00268-008-9850-z.PubMedCrossRef

32.

Shaw A, Collins EE, Fakis A, Patel P, Semeraro D, Lund JN. Colorectal surgeons and biomedical scientists improve lymph node harvest in colorectal cancer. Tech Coloproctol. 2008;12(4):295–8. doi:10.1007/s10151-008-0438-2.PubMedCrossRef

33.

Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99(6):433–41. doi:10.1093/jnci/djk092.PubMedCrossRef

34.

Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, et al. The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer. J Gastrointest Surg. 2007;11(5):660–5. doi:10.1007/s11605-007-0119-x.PubMedCrossRef

35.

Yoshimatsu K, Ishibashi K, Umehara A, Yokomizo H, Yoshida K, Fujimoto T, et al. How many lymph nodes should be examined in Dukes’ B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology. 2005;52(66):1703–6.PubMed

36.

Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(15):2912–9. doi:10.1200/jco.2003.05.062.CrossRef

37.

Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26(2):179–89.PubMedCrossRef

38.

Albayrak Y, Oren D, Gundogdu C, Kurt A. Intraoperative sentinel lymph node mapping in patients with colon cancer: study of 38 cases. Turk J Gastroenterol: Off J Turk Soc Gastroenterol. 2011;22(3):286–92.CrossRef

39.

Markl B, Arnholdt HM, Jahnig H, Spatz H, Anthuber M, Oruzio DV, et al. A new concept for the role of ex vivo sentinel lymph nodes in node-negative colorectal cancer. Ann Surg Oncol. 2010;17(10):2647–55. doi:10.1245/s10434-010-1030-3.PubMedCrossRef

40.

Scabini S. Sentinel node biopsy in colorectal cancer: must we believe it? World J Gastrointest Surg. 2010;2(1):6–8. doi:10.4240/wjgs.v2.i1.6.PubMedPubMedCentralCrossRef

41.

Sommariva A, Donisi PM, Gnocato B, Vianello R, Stracca Pansa V, Zaninotto G. Factors affecting false-negative rates on ex vivo sentinel lymph node mapping in colorectal cancer. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2010;36(2):130–4. doi:10.1016/j.ejso.2009.06.007.CrossRef

42.

Wiese D, Sirop S, Yestrepsky B, Ghanem M, Bassily N, Ng P, et al. Ultrastaging of sentinel lymph nodes (SLNs) vs. non-SLNs in colorectal cancer—do we need both? Am J Surg. 2010;199(3):354–8. doi:10.1016/j.amjsurg.2009.08.032. discussion 8.PubMedCrossRef

43.

Chan SH, Ng C, Looi LM. Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer. ANZ J Surg. 2008;78(9):775–9. doi:10.1111/j.1445-2197.2008.04648.x.PubMedCrossRef

44.

Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer (Oxford, England: 1990). 2005;41(2):272–9. doi:10.1016/j.ejca.2004.10.010.CrossRef

45.

Senthil M, Trisal V, Paz IB, Lai LL. Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type. Arch of Surg (Chicago, Ill: 1960). 2010;145(9):840–3. doi:10.1001/archsurg.2010.182.CrossRef

46.

Porter GA, Urquhart R, Bu J, Johnson P, Grunfeld E. The impact of audit and feedback on nodal harvest in colorectal cancer. BMC Cancer. 2011;11:2. doi:10.1186/1471-2407-11-2.PubMedPubMedCentralCrossRef

47.

Benson 3rd AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22(16):3408–19. doi:10.1200/jco.2004.05.063.CrossRef

48.

Romanus D, Weiser MR, Skibber JM, Ter Veer A, Niland JC, Wilson JL, et al. Concordance with NCCN colorectal cancer guidelines and ASCO/NCCN quality measures: an NCCN institutional analysis. J Natl Compr Canc Netw. 2009;7(8):895–904.PubMed

49.

Vather R, Sammour T, Kahokehr A, Connolly A, Hill A. Quantitative lymph node evaluation as an independent marker of long-term prognosis in stage III rectal cancer. ANZ J Surg. 2011;81(12):883–8. doi:10.1111/j.1445-2197.2010.05595.x.PubMedCrossRef

50.

Nagtegaal ID, Tot T, Jayne DG, McShane P, Nihlberg A, Marshall HC, et al. Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(18):2487–92. doi:10.1200/jco.2011.34.6429.CrossRef

51.

Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(2):256–63. doi:10.1200/jco.2009.23.9194.CrossRef

52.

Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(2):264–71. doi:10.1200/jco.2009.24.0952.CrossRef

53.

•• Shia J, Wang H, Nash GM, Klimstra DS. Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J Am Coll Surg. 2012;214(3):348–55. doi:10.1016/j.jamcollsurg.2011.11.010. This article extensively reviews the overall risk-benefit profile of lymph node harvest for the colorectal cancer.PubMedCrossRef

54.

Stocchi L, Fazio VW, Lavery I, Hammel J. Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage II colon carcinoma. is a minimum of 12 examined lymph nodes sufficient? Ann Surg Oncol. 2011;18(2):405–12. doi:10.1245/s10434-010-1308-5.PubMedCrossRef

55.

Noura S, Ohue M, Kano S, Shingai T, Yamada T, Miyashiro I, et al. Impact of metastatic lymph node ratio in node-positive colorectal cancer. World J Gastrointest Surg. 2010;2(3):70–7. doi:10.4240/wjgs.v2.i3.70.PubMedPubMedCentralCrossRef

56.

Park IJ, Choi GS, Jun SH. Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio. J Surg Oncol. 2009;100(3):240–3. doi:10.1002/jso.21273.PubMedCrossRef

57.

Bilimoria KY, Palis B, Stewart AK, Bentrem DJ, Freel AC, Sigurdson ER, et al. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008;51(2):154–61. doi:10.1007/s10350-007-9114-2.PubMedCrossRef

58.

Wang J, Hassett JM, Dayton MT, Kulaylat MN. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008;15(6):1600–8. doi:10.1245/s10434-007-9716-x.PubMedCrossRef

59.

Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298(18):2149–54. doi:10.1001/jama.298.18.2149.PubMedCrossRef

60.

Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol. 2006;93(6):439–45. doi:10.1002/jso.20499.PubMedCrossRef

61.

Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244(4):602–10. doi:10.1097/01.sla.0000237655.11717.50.PubMedPubMedCentral

62.

Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(34):8706–12. doi:10.1200/jco.2005.02.8852.CrossRef

63.

Kukreja SS, Esteban-Agusti E, Velasco JM, Hieken TJ. Increased lymph node evaluation with colorectal cancer resection: does it improve detection of stage III disease? Arch Surg (Chicago, Ill: 1960). 2009;144(7):612–7. doi:10.1001/archsurg.2009.112.CrossRef

64.

Curti G, Maurer CA, Buchler MW. Colorectal carcinoma: is lymphadenectomy useful? Dig Surg. 1998;15(3):193–208.PubMedCrossRef

65.

Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes’ B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83(4):666–72.PubMedCrossRef

66.

Tepper JE, O’Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson 3rd AB, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19(1):157–63.CrossRef

67.

Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002;26(3):384–9. doi:10.1007/s00268-001-0236-8.PubMedCrossRef

68.

Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235(4):458–63.PubMedPubMedCentralCrossRef

69.

Law CH, Wright FC, Rapanos T, Alzahrani M, Hanna SS, Khalifa M, et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol. 2003;84(3):120–6. doi:10.1002/jso.10309.PubMedCrossRef

70.

Vather R, Sammour T, Zargar-Shoshtari K, Metcalf P, Connolly A, Hill A. Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer. Int J Colorectal Dis. 2009;24(3):283–8. doi:10.1007/s00384-008-0540-y.PubMedCrossRef

71.

Choi HK, Law WL, Poon JT. The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer. 2010;10:267. doi:10.1186/1471-2407-10-267.PubMedPubMedCentralCrossRef

72.

•• Han J, Noh GT, Yeo SA, Cheong C, Cho MS, Hur H, et al. The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer. Medicine. 2016;95(38):e4891. doi:10.1097/md.0000000000004891. This is the most recent study supporting the role of lymph node harvest in the colorectal cancer.PubMedPubMedCentralCrossRef

73.

van der Zaag ES, Kooij N, van de Vijver MJ, Bemelman WA, Peters HM, Buskens CJ. Diagnosing occult tumour cells and their predictive value in sentinel nodes of histologically negative patients with colorectal cancer. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2010;36(4):350–7. doi:10.1016/j.ejso.2009.11.008.CrossRef

74.

van der Zaag ES, Bouma WH, Tanis PJ, Ubbink DT, Bemelman WA, Buskens CJ. Systematic review of sentinel lymph node mapping procedure in colorectal cancer. Ann Surg Oncol. 2012;19(11):3449–59. doi:10.1245/s10434-012-2417-0.PubMedCrossRef

75.

• Saha S, Johnston G, Korant A, Shaik M, Kanaan M, Johnston R, et al. Aberrant drainage of sentinel lymph nodes in colon cancer and its impact on staging and extent of operation. Am J Surg. 2013;205(3):302–5. doi:10.1016/j.amjsurg.2012.10.029. This is the most recent study to suggest that retrieval of lymph node has a role in the treatment of colorectal cancer.PubMedCrossRef

76.

Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, et al. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg. 2007;245(6):858–63. doi:10.1097/01.sla.0000250428.46656.7e.PubMedPubMedCentralCrossRef

77.

Retter SM, Herrmann G, Schiedeck TH. Clinical value of sentinel node mapping in carcinoma of the colon. Color Dis: Off J Assoc Coloproctology Great Br Irel. 2011;13(8):855–9. doi:10.1111/j.1463-1318.2010.02293.x.CrossRef

78.

Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg. 1982;69(10):613–6.PubMedCrossRef

79.

Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Color Dis: Off J Assoc Coloproctology Great Br Irel. 2009;11(4):354–64. doi:10.1111/j.1463-1318.2008.01735.x. discussion 64-5.CrossRef

80.

Ostadi MA, Harnish JL, Stegienko S, Urbach DR. Factors affecting the number of lymph nodes retrieved in colorectal cancer specimens. Surg Endosc. 2007;21(12):2142–6. doi:10.1007/s00464-007-9414-6.PubMedCrossRef

81.

Gelos M, Gelhaus J, Mehnert P, Bonhag G, Sand M, Philippou S, et al. Factors influencing lymph node harvest in colorectal surgery. Int J Colorectal Dis. 2008;23(1):53–9. doi:10.1007/s00384-007-0378-8.PubMedCrossRef

82.

Scabini S, Rimini E, Romairone E, Scordamaglia R, Pertile D, Testino G, et al. Factors that influence 12 or more harvested lymph nodes in resective R0 colorectal cancer. Hepatogastroenterology. 2010;57(101):728–33.PubMed

83.

Jakub JW, Russell G, Tillman CL, Lariscy C. Colon cancer and low lymph node count: who is to blame? Arch Surg (Chicago, Ill: 1960). 2009;144(12):1115–20. doi:10.1001/archsurg.2009.210.CrossRef

84.

Evans MD, Barton K, Rees A, Stamatakis JD, Karandikar SS. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes’ stage B disease. Color Dis: Off J Assoc Coloproctology Great Br Irel. 2008;10(2):157–64. doi:10.1111/j.1463-1318.2007.01225.x.

85.

West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(2):272–8. doi:10.1200/jco.2009.24.1448.CrossRef

86.

Nash GM, Row D, Weiss A, Shia J, Guillem JG, Paty PB, et al. A predictive model for lymph node yield in colon cancer resection specimens. Ann Surg. 2011;253(2):318–22. doi:10.1097/SLA.0b013e318204e637.PubMedCrossRef

87.

Tekkis PP, Smith JJ, Heriot AG, Darzi AW, Thompson MR, Stamatakis JD. A national study on lymph node retrieval in resectional surgery for colorectal cancer. Dis Colon Rectum. 2006;49(11):1673–83. doi:10.1007/s10350-006-0691-2.PubMedCrossRef

88.

Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2009;10(1):44–52. doi:10.1016/s1470-2045(08)70310-3.PubMedCrossRef

89.

Lourenco T, Murray A, Grant A, McKinley A, Krukowski Z, Vale L. Laparoscopic surgery for colorectal cancer: safe and effective?—a systematic review. Surg Endosc. 2008;22(5):1146–60. doi:10.1007/s00464-007-9686-x.PubMedCrossRef

90.

•• Wu Z, Zhang S, Aung LH, Ouyang J, Wei L. Lymph node harvested in laparoscopic versus open colorectal cancer approaches: a meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012;22(1):5–11. doi:10.1097/SLE.0b013e3182432b49. This is the most recent meta-analysis review of the lymph node harvest in laparoscopic surgery and open surgery.PubMedCrossRef

91.

Lujan J, Valero G, Hernandez Q, Sanchez A, Frutos MD, Parrilla P. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg. 2009;96(9):982–9. doi:10.1002/bjs.6662.PubMedCrossRef

92.

Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996;106(2):209–16.PubMedCrossRef

93.

Fan L, Levy M, Aguilar CE, Mertens RB, Dhall D, Frishberg DP, et al. Lymph node retrieval from colorectal resection specimens for adenocarcinoma: is it worth the extra effort to find at least 12 nodes? Color Dis: Off J Assoc Coloproctology Great Br Irel. 2011;13(12):1377–83. doi:10.1111/j.1463-1318.2010.02472.x.CrossRef

94.

Linebarger JH, Mathiason MA, Kallies KJ, Shapiro SB. Does obesity impact lymph node retrieval in colon cancer surgery? Am J Surg. 2010;200(4):478–82. doi:10.1016/j.amjsurg.2009.12.012.PubMedCrossRef

95.

• Kuijpers CC, van Slooten HJ, Schreurs WH, Moormann GR, Abtahi MA, Slappendel A, et al. Better retrieval of lymph nodes in colorectal resection specimens by pathologists’ assistants. J Clin Pathol. 2013;66(1):18–23. doi:10.1136/jclinpath-2012-201089. This is the most recent study supporting the role of lymph node harvest in the colorectal cancer.PubMedCrossRef

96.

Schofield JB, Mounter NA, Mallett R, Haboubi NY. The importance of accurate pathological assessment of lymph node involvement in colorectal cancer. Color Dis: Off J Assoc Coloproctology Great Br Irel. 2006;8(6):460–70. doi:10.1111/j.1463-1318.2006.01044.x.CrossRef

97.

Rahbari NN, Bork U, Motschall E, Thorlund K, Buchler MW, Koch M, et al. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(1):60–70. doi:10.1200/jco.2011.36.9504.CrossRef

98.

Wright FC, Law CH, Berry S, Smith AJ. Clinically important aspects of lymph node assessment in colon cancer. J Surg Oncol. 2009;99(4):248–55. doi:10.1002/jso.21226.PubMedCrossRef

99.

Markl B, Kerwel TG, Wagner T, Anthuber M, Arnholdt HM. Methylene blue injection into the rectal artery as a simple method to improve lymph node harvest in rectal cancer. Mod Pathol: Off J U S Can Acad Patho, Inc. 2007;20(7):797–801. doi:10.1038/modpathol.3800824.CrossRef

100.

Markl B, Schaller T, Krammer I, Cacchi C, Arnholdt HM, Schenkirsch G, et al. Methylene blue-assisted lymph node dissection technique is not associated with an increased detection of lymph node metastases in colorectal cancer. Mod Pathol: Off J U S Can Acad Patho, Inc. 2013;26(9):1246–54. doi:10.1038/modpathol.2013.61.CrossRef

101.

Basten O, Bandorski D, Bismarck C, Neumann K, Fisseler-Eckhoff A. Acetone compression. A fast, standardized method to investigate gastrointestinal lymph nodes. Pathologe. 2010;31(3):218–24. doi:10.1007/s00292-009-1256-7.PubMedCrossRef

102.

Gehoff A, Basten O, Sprenger T, Conradi LC, Bismarck C, Bandorski D, et al. Optimal lymph node harvest in rectal cancer (UICC stages II and III) after preoperative 5-FU-based radiochemotherapy. Acetone compression is a new and highly efficient method. Am J Surg Pathol. 2012;36(2):202–13. doi:10.1097/PAS.0b013e31823fa35b.PubMedCrossRef

103.

Baxter NN, Ricciardi R, Simunovic M, Urbach DR, Virnig BA. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum. 2010;53(1):65–70. doi:10.1007/DCR.0b013e3181c70425.PubMedCrossRef

104.

Nathan H, Shore AD, Anders RA, Wick EC, Gearhart SL, Pawlik TM. Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital? J Gastrointest Surg. 2011;15(3):471–9. doi:10.1007/s11605-010-1410-9.PubMedCrossRef

105.

Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR. Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer. 2010;116(11):2560–70. doi:10.1002/cncr.25032.PubMedPubMedCentralCrossRef

106.

Chen SL, Steele SR, Eberhardt J, Zhu K, Bilchik A, Stojadinovic A. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Ann Surg. 2011;253(1):82–7. doi:10.1097/SLA.0b013e3181ffa780.PubMedCrossRef

107.

Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93(8):583–96.PubMedCrossRef

108.

Doll D, Gertler R, Maak M, Friederichs J, Becker K, Geinitz H, et al. Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg. 2009;33(2):340–7. doi:10.1007/s00268-008-9838-8.PubMedCrossRef

109.

Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, et al. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(34):4568–73. doi:10.1200/jco.2011.37.2235.CrossRef

110.

Rullier A, Laurent C, Capdepont M, Vendrely V, Belleannee G, Bioulac-Sage P, et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol. 2008;32(1):45–50. doi:10.1097/PAS.0b013e3180dc92ab.PubMedCrossRef

111.

Benson 3rd AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, et al. Colon cancer, version 3.2014. J Natl Compr Canc Netw. 2014;12(7):1028–59.PubMed

112.

Benson 3rd AB, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, et al. Rectal cancer, version 2.2015. J Natl Compr Canc Netw. 2015;13(6):719–28. quiz 28.PubMed

113.

Lee S, Hofmann LJ, Davis KG, Waddell BE. Lymph node evaluation of colon cancer and its association with improved staging and survival in the Department of Defense Health Care System. Ann Surg Oncol. 2009;16(11):3080–6. doi:10.1245/s10434-009-0620-4.PubMedCrossRef

114.

Hermanek P. Oncologic surgery/pathologic-anatomic viewpoint. Langenbecks Arch Chir Suppl Kongressbd Dtsch Ges Chir Kongressbd. 1991:277–81.

115.

Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76(11):1165–7.PubMedCrossRef

116.

Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97(3):219–25. doi:10.1093/jnci/dji020.PubMedCrossRef

117.

National Bowel Cncer Audit 2009. Available from: URL: http: //www.acpgbi.org.uk/assets/documents/National_Bowel_Cancer_Audit_2009_Interactive_for_web_051109.pdf.

Title: Lymphadenectomy in Colorectal Cancer: Therapeutic Role and How Many Nodes Are Needed for Appropriate Staging?
Authors: Jeonghee Han
Kyung Tae Noh
Byung Soh Min
Publication date: 01-02-2017
Publisher: Springer US
Published in: Current Colorectal Cancer Reports / Issue 1/2017
Print ISSN: 1556-3790
Electronic ISSN: 1556-3804
DOI: https://doi.org/10.1007/s11888-017-0349-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes in Rectal Cancer

Molecular Stratification of Colorectal Cancer: Moving from the Laboratory to Clinical Practice

Current Status of Laparoscopic Surgery in Colorectal Cancer

Microsatellite Instability Pathway and EMAST in Colorectal Cancer

Local Excision Versus Total Mesorectal Excision for Clinical Stage I (cT1–cT2) Rectal Cancer

Current Status of the Watch-and-Wait Policy for Patients with Complete Clinical Response Following Neoadjuvant Chemoradiation in Rectal Cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer